eISSN: 1733-7607
ISSN: 1733-4101
Leczenie Ran
Current issue Archive Manuscripts accepted About the journal Editorial board Subscription Contact Instructions for authors Ethical standards and procedures
4/2022
vol. 19
 
Share:
Share:
abstract:
Case report

Pyoderma gangrenosum in a patient with Down syndrome

Arletta Kozłowska
1
,
Anna Surówka
2
,
Andrzej Jaworek
1
,
Anna Wojas-Pelc
1

  1. Katedra i Klinika Dermatologii, Uniwersytet Jagielloński Collegium Medicum w Krakowie
  2. Studenckie Koło Naukowe, Katedra i Klinika Dermatologii, Uniwersytet Jagielloński Collegium Medicum w Krakowie
LECZENIE RAN 2022; 19 (4): 123-128
Online publish date: 2022/12/23
View full text Get citation
 
PlumX metrics:
Pyoderma gangrenosum (PG) is a rare, potentially fatal skin disease with the formation of a painful, rapidly progressing (dynamic) necrotic ulcer with undermined blue-violet margins. PG in 50-70% of patients coexists with other systemic diseases: inflammatory bowel diseases (most frequent), arthritis (most often rheumatoid arthritis – RA), cancer of internal organs, myeloproliferative syndromes, and other dermatoses.

21-chromosome trisomy (Down’s syndrome – DS) is the most common autosomal genomic mutation among liveborn infants. Due to the coexistence of congenital defects, greater susceptibility to infections, autoimmune diseases, and greater risk of developing neoplastic diseases, patients suffering from DS require multidisciplinary medical supervision.

The aim of the study was to present a 22-year-old patient with DS and coexisting PG hospitalized at the Clinical Department of Dermatology, University Hospital in Krakow. The reminder of this rare and dangerous dermatosis seems to be purposeful and useful, especially for specialists dealing with the treatment of chronic wounds.
keywords:

Down syndrome, pyoderma gangrenosum, diagnostics, treatment

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.